Goethe-Universität Frankfurt am Main

Chemoradiotherapy plus induction versus consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-12 multicentre, open-label, randomised, phase 2 trial (2019) Fokas E, Allgaeuer M, Polat B, Klautke G, Grabenbauer G, Fietkau R, Kuhnt T, et al. Conference contribution Analyses of association of psoriatic arthritis and psoriasis vulgaris with functional NCF1 variants (2019) Löhr S, Ekici AB, Uebe S, Büttner C, Köhm M, Behrens F, Böhm B, et al. Journal article Chemo-RT plus induction or consolidation chemotherapy for rectal cancer: a randomised phase 2 trial (2019) Fokas E, Allgaeuer M, Polat B, Klautke G, Grabenbauer G, Fietkau R, Kuhnt T, et al. Conference contribution QoL after multimodal treatment of rectal cancer with/without oxaliplatin (phase 3, CAO/ARO/AIO-04) (2019) Kosmala R, Fokas E, Flentje M, Sauer R, Liersch T, Graeven U, Fietkau R, et al. Conference contribution Process Evaluation of a Medical Student-Delivered Smoking Prevention Program for Secondary Schools: Protocol for the Education Against Tobacco Cluster Randomized Trial (2019) Brinker TJ, Buslaff F, Suhre JL, Silchmueller MP, Divizieva E, Wilhelm J, Hillebrand G, et al. Journal article Sasanian trade networks and the Silk Road – a case study on Gird-i Qilirkh in the Sharezur valley (2019) Tamm A, Haddad L Book chapter / Article in edited volumes Efficacy of GKT831 in patients with primary biliary cholangitis and inadequate response to ursodeoxycholic acid: Interim efficacy results of a phase 2 clinical trial (2019) Dalekos G, Invernizzi P, Nevens F, Hans VV, Zigmond E, Andrade RJ, Ben Ari Z, et al. Conference contribution Therapeutic efficacy of the Ginkgo special extract EGb761®within the framework of the mitochondrial cascade hypothesis of Alzheimer’s disease (2019) Müller WE, Eckert A, Eckert GP, Fink H, Friedland K, Gauthier S, Hoerr R, et al. Journal article, Review article Management of Pregnancy in Inherited Dysfibrinogenemia after Recurrent Miscarriage (2019) Zimmermann R, Peisl J, Geisen C, Koerber S, Achenbach S, Hackstein H Journal article Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial (2019) Herrlinger U, Tzaridis T, Mack F, Steinbach JP, Schlegel U, Sabel M, Hau P, et al. Journal article